<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The clinical and biological features of a series of 27 patients with the recently described <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> are reported </plain></SENT>
<SENT sid="1" pm="."><plain>Most of them belonged to a cohort of 90 patients who were carriers of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, which had been detected in the systematic evaluation of <z:hpo ids='HP_0003645'>prolonged activated partial thromboplastin times</z:hpo> in our hospital </plain></SENT>
<SENT sid="2" pm="."><plain>Since the diagnosis they underwent a prospective protocol of follow up, with a peak follow up period of 9 years </plain></SENT>
<SENT sid="3" pm="."><plain>The mean age of the 27 patients was 40.8 years and there were virtually no differences between sexes </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0004936'>Venous thrombosis</z:hpo> was the most common clinical finding (16 episodes in 14 of the 27 patients) </plain></SENT>
<SENT sid="5" pm="."><plain>The most prevalent laboratory findings were <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and IgG anticardiolipin antibodies </plain></SENT>
</text></document>